Etropolski, MD, Mila, United States

• Journal of Opioid Management Vol. 9 No. 5 (2013): September/October - Articles
  A pooled analysis of patient-specific factors and efficacy and tolerability of tapentadol extended release treatment for moderate to severe chronic pain
  Abstract
• Journal of Opioid Management Vol. 11 No. 3 (2015): May/June - Articles
  Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency
  Abstract
• Journal of Opioid Management Vol. 11 No. 5 (2015): September/October - Articles
  Tolerability and efficacy of tapentadol extended release in elderly patients ≥75 years of age with chronic osteoarthritis knee or low back pain
  Abstract
• Journal of Opioid Management Vol. 10 No. 3 (2014): May/June - Articles
  Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: Results of in vitro laboratory analyses
  Abstract